In the latest report available in LSI's Medtech Pro Platform, Impact of 2020 Crisis on Global Medical Devices & Diagnostics Market, new forecasts and analysis based on the impact of COVID-19 are provided. More specifically, the report details the impact of the crisis annually for 2020 through 2025 on:
The presence of an arrhythmia is confirmed when the heart beats at an irregular rate. Persistent arrhythmia necessitates clinical evaluation and may require some form of intervention to prevent the irregularity from becoming life-threatening. When left untreated, serious forms of arrhythmia can lead to serious complications, such as stroke and heart failure. Recurring arrhythmia can be managed with a number of therapeutic options, including pharmaceuticals, implantable devices (e.g. pacemakers), and ablative procedures.
Stroke is the second largest cause of death globally, claiming an estimated 5.5 million lives annually. The burden of stroke is expected to worsen in the future as a result of demographic and lifestyle changes in developed and developing countries. During the acute stage there are several pharmaceuticals and surgical procedures available to assist healthcare providers manage stroke patients. This market research report provides forecasts and analysis of the embolization products used in the management and treatment of stroke. In addition to market forecasts, this report provides insights into the leading competitors in the cerebral embolization products market.
The ambitious goal for healthcare in Brazil is “health for all”. Formed in 1988, Brazil’s Sistema Único da Saúde (SUS) is one of the largest public health systems in the world. Universal healthcare in Brazil is funded through local and federal taxes provided by government and private institutions. The SUS ensures that Brazilian residents and foreigners in Brazil have access to public healthcare. It is estimated that 75% of Brazil’s 200+ million residents is reliant on the SUS for access to healthcare.
In our last few posts, we’ve been giving you reasons to attend Emerging Medtech Summit 2020. This industry-leading conference, hosted by Life Science Intelligence, will be held February 18th through the 20th in Dana Point, California, at The Ritz-Carlton Laguna Niguel.
Canada’s healthcare system has been touted and adored by some of the country’s southern neighbors for years. Compared to the “hands-off” approach to healthcare demonstrated by the US government, healthcare in Canada has been highly regulated in an attempt to control costs. Canadian life expectancy has continued to improve in the last two decades, in part due to access to advanced healthcare therapies and pharmaceuticals as is common in Western countries.
The United States is the largest healthcare market in the world. Boasting the third largest population (~330 million people) and a well-developed healthcare system, the US remains the key market to target for the commercialization of healthcare solutions.
Healthcare in China is in a constant state of reform as the system evolves to meet the unique burdens of the country which rapidly became the world’s second largest economy. With a population of approximately 1.4 billion people, demand for healthcare services is at an all-time high in China, with many hospitals understaffed and overwhelmed by demand.
Substantial increases in surgical procedure volumes are being projected across most medical segments as a result of a number of factors, including but not limited to:
With a growing focus on the global need for healthcare that is affordable and accessible to anyone, anywhere in the world, comes a look at technologies that are designed to lessen the gap between quality care and individuals outside of developed cities and countries.